Silica Aerogels/Xerogels Modified with Nitrogen-Containing Groups for Heavy Metal Adsorption

Heavy metals are common inorganic pollutants found in the environment that have to be removed from wastewaters and drinking waters. In this work, silica-derived aerogels and xerogels were modified via a co-precursor method to obtain functional adsorbents for metal cations. A total of six formulations based upon four different functional precursors were prepared. The materials' structural characterization revealed a decreased porosity and surface area on modified samples, more prominent in xerogel counterparts. Preliminary tests were conducted, and the prepared samples were also compared to activated carbon. Three samples were selected for in-depth studies. Isotherm studies revealed that the pre-selected samples remove well copper, lead, cadmium and nickel, and with similar types of interactions, following a Langmuir trend. The adsorption kinetics starts very fast and either equilibrium is reached quickly or slowly, in a two-stage process attributed to the existence of different types of active sites. Based on the previous tests, the best sample, prepared by mixing different functional co-precursors, was selected and its behavior was studied under different temperatures. For this material, the adsorption performance at 20 °C is dependent on the cation, ranging from 56 mg·g-1 for copper to 172 mg·g-1 for lead

Insights on toxicity, safe handling and disposal of silica aerogels and amorphous nanoparticles

Amorphous forms of silica have always raised a lot of interest by the scientific community and are nowadays rapidly growing in commercial applications. These are commercialized as aerogels or as nanoparticles, which can feature many similarities, not only in the synthesis process but also because clusters of nanoparticles are commonly released from aerogels. Nevertheless, the health effects of amorphous silica materials are not fully understood, as occurs with many other nanoforms. Amorphous silica is known to be less toxic than its crystalline form, but toxicity studies, regulatory aspects and handling practices are still scarce. In this work, the knowledge on toxicity of amorphous silica nanostructures and suitable regulations are reviewed. Furthermore, relevant safety practices for handling these materials are discussed and strategies used to recycle and dispose them are summarized.European Regional Development Fund (ERDF) | Ref. CENTRO-01-0145-FEDER-029533Fundação para a Ciência e a Tecnologia | Ref. PTDC / EQU-EQU / 29533/2017European Commission y Fundação para a Ciência e a Tecnologia | Ref. POCI-01-0145-FEDER-032061European Commission y Fundação para a Ciência e a Tecnologia | Ref. PTDC / ECI-EGC / 32061/2017Xunta de Galicia | Ref. ED431F 2016/010Xunta de Galicia | Ref. ED431C 2020/17Ministerio de Ciencia, Innovación y Universidades | Ref. RTI2018-094131-A-I00Fundação para a Ciência e Tecnologia | Ref. SFRH / BD / 131280/2017European Commission y Consejo Superior de Investigaciones Científicas | Ref. RYC2014-15239Fundação para a Ciência e Tecnologia | Ref. POCI-01-0145-FEDER- 006910Fundação para a Ciência e Tecnologia | Ref. POCI-01-0145-FEDER-00763

Quality upgrades and bypass under mandatory access

Access regulation, Quality upgrades, Investment bypass, L41, L43, L51, L96,

Reduced Chitosan as a Strategy for Removing Copper Ions from Water

Toxic heavy metals are priority pollutants in wastewater, commonly present in dangerous concentrations in many places across the globe. Although in trace quantities copper is a heavy metal essential to human life, in excess it causes various diseases, whereby its removal from wastewater is a necessity. Among several reported materials, chitosan is a highly abundant, non-toxic, low-cost, biodegradable polymer, comprising free hydroxyl and amino groups, that has been directly applied as an adsorbent or chemically modified to increase its performance. Taking this into account, reduced chitosan derivatives (RCDs 1-4) were synthesised by chitosan modification with salicylaldehyde, followed by imine reduction, characterised by RMN, FTIR-ATR, TGA and SEM, and used to adsorb Cu(II) from water. A reduced chitosan (RCD3), with a moderate modification percentage (43%) and a high imine reduction percentage (98%), proved to be more efficient than the remainder RCDs and even chitosan, especially at low concentrations under the best adsorption conditions (pH 4, RS/L = 2.5 mg mL-1). RCD3 adsorption data were better described by the Langmuir-Freundlich isotherm and the pseudo-second-order kinetic models. The interaction mechanism was assessed by molecular dynamics simulations, showing that RCDs favour Cu(II) capture from water compared to chitosan, due to a greater Cu(II) interaction with the oxygen of the glucosamine ring and the neighbouring hydroxyl groups

Hypoglycaemic activity of Bauhinia holophylla through GSK3-β inhibition and glycogenesis activation

Context: Bauhinia L. species, including Bauhinia holophylla (Bong.) Steud. (Fabaceae), have traditionally been used to treat diabetes. Bauhinia is a complex botanical genus, and the indiscriminate use of the diverse Bauhinia species is reflected in the experimental divergence of their medicinal potential. Objective: The hypoglycaemic and hypolipidaemic effects, molecular mechanism of action and phytochemical properties of an authentic extract of B. holophylla leaves were evaluated. Materials and methods: A phytochemical study of a 70% EtOH extract was performed using FIA-ESI-IT-MS/MSn and HPLC-PAD-ESI-IT-MS. The extract (200 or 400 mg/kg b.w.) was administered for 14 days to streptozotocin-induced diabetic Swiss mice. Glucose tolerance and insulin sensitivity, blood parameters, gene and protein expression, and the in vivo and in vitro inhibition of intestinal glucosidases were assessed. Results: HPLC-PAD-ESI-IT-MS analysis identified flavonoid derivatives of quercetin, myricetin, luteolin and kaempferol. Treatment with 400 mg/kg of the extract reduced blood glucose (269.0 ± 32.4 mg/dL vs. 468.0 ± 32.2 mg/dL for diabetic animals), improved glucose tolerance, decreased cholesterol and triglyceride levels, and increased the mRNA expression of proteins involved in glucogenesis in the liver and muscle, such as PI3-K/Akt, GS, GSK3-β (ser-9), AMPK and Glut4. The activity of intestinal maltase was inhibited in vitro (IC50: 43.0 µg/mL for the extract compared to 516.4 µg/mL for acarbose) and in vivo. Discussion and conclusions: Treatment with B. holophylla was associated with a marked hypoglycaemic effect through the stimulation of glycogenesis and inhibition of gluconeogenesis and intestinal glucose absorption, without increasing basal insulinaemia

Safety of hospital discharge before return of bowel function after elective colorectal surgery

Background: Ileus is common after colorectal surgery and is associated with an increased risk of postoperative complications. Identifying features of normal bowel recovery and the appropriateness for hospital discharge is challenging. This study explored the safety of hospital discharge before the return of bowel function.Methods: A prospective, multicentre cohort study was undertaken across an international collaborative network. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The main outcome of interest was readmission to hospital within 30 days of surgery. The impact of discharge timing according to the return of bowel function was explored using multivariable regression analysis. Other outcomes were postoperative complications within 30 days of surgery, measured using the Clavien-Dindo classification system.Results: A total of 3288 patients were included in the analysis, of whom 301 (9.2 per cent) were discharged before the return of bowel function. The median duration of hospital stay for patients discharged before and after return of bowel function was 5 (i.q.r. 4-7) and 7 (6-8) days respectively (P < 0.001). There were no significant differences in rates of readmission between these groups (6.6 versus 8.0 per cent; P = 0.499), and this remained the case after multivariable adjustment for baseline differences (odds ratio 0.90, 95 per cent c.i. 0.55 to 1.46; P = 0.659). Rates of postoperative complications were also similar in those discharged before versus after return of bowel function (minor: 34.7 versus 39.5 per cent; major 3.3 versus 3.4 per cent; P = 0.110).Conclusion: Discharge before return of bowel function after elective colorectal surgery appears to be safe in appropriately selected patients